News
For this #OMFScienceWednesday we share Cort Johnson’s article in HealthRising highlighting Dr. Davis and Dr. Bateman’s presentation at the 2018 Brain Science Conference. By Cort Johnson Dynamic Duo It seemed like a dicey thing – a talk on chronic fatigue syndrome (ME/CFS) that seemingly had little to do with the conference. The Brain Science Conference is a...
On this #OMFScienceWednesday we introduce you to researcher Robert Phair, PhD, running the OMF-funded metabolic trap project. Today, Dr. Phair shares his personal connections and how he became a part of OMF’s End ME/CFS research project. “I was a professor of physiology and biomedical engineering at The Johns Hopkins School of Medicine for 16 years...
We are pleased to share a new research update by OMF’s Scientific Advisory Board member, Mark M. Davis, PhD, produced by Ashley Haugen for this #OMFScienceWednesday. Dr. Mark Davis, Director of the Stanford Institute for Immunity, Transplantation, and Infection, talks about his work with T-cells to understand their role in ME/CFS and to determine if...
This #OMFScienceWednesday we introduce the magnetic levitation device research by Gozde Durmus, PhD, in collaboration with Ronald W. Davis, PhD. This project is a part of the ME/CFS Collaborative Research Center at Stanford University funded by OMF. This device uses a ferrofluid in a glass capillary surrounded by permanent magnets. This generates a density gradient...
BIG NEWS on this #OMFScienceWednesday: OMF creates new Harvard ME/CFS Collaborative Research Center and expands Stanford Data Center ME/CFS Collaborative Research Center at the Harvard: We are proud to announce that OMF has funded $1.8 million for the establishment of a new ME/CFS Collaborative Research Center at the Harvard Medical School affiliated hospitals, which includes Massachusetts...
On this #OMFScienceWednesday we highlight Dr. Ron Davis’s team at Stanford University’s work to develop two technologies that can be used to distinguish ME/CFS patient blood samples from healthy blood samples. Nanoneedle: 10 patients and 10 controls were tested on the nanoneedle biosensor platform. This is a nanofabricated device that measures electrical impedance from a...
On this #OMFScienceWednesday, we review the Severely ill Big Data Study. This study, led by Drs. Davis and Xiao, included over 1,000 tests per patient, producing, to our knowledge, the biggest dataset ever generated in a cohort of ME/CFS patients. This big data study examined the patients’ genome, gene expression, metabolomics, microbiome, cell-free DNA sequencing...
This week for #OMFScienceWednesday we look in our archives and re-share with you an earlier post about personalized medicine. In honor of this week’s conference at Stanford University, on this #OMFScienceWednesday we ask the question: what is personalized health? Whether you call it personalized medicine, precision health, or P4 medicine, we are talking about a current revolution...
Ronald W. Davis, PhD, a pre-eminent scientist at Stanford and our own scientific advisory board director, in this interview mentions 4 prospective biomarkers, tells of the OMF-funded research now being pursued, and tells of the biological abnormalities being seen in ME/CFS patients. He also gives some advice for healthcare providers. The interviewer is Deborah Becker...